Study to Evaluate the Safety of Twice Daily Oral Carvedilol

PHASE3CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
Congestive Heart Failure
Interventions
DRUG

Carvedilol

Trial Locations (17)

19104

Children's Hospital of Philadelphia, Philadelphia

33101

University of Miami, Miami

37332

Vanderbilt Children's Hospital, Nashville

48109

C.S. Mott Children's Hospital, Ann Arbor

60614

Children's Memorial Hospital, Chicago

77030

Texas Children's Hospital, Houston

80218

University of Colorado, Denver

84132

University of Utah, Salt Lake City

90025

Mattel Children's Hospital at UCLA, Los Angeles

90027

Children's Hospital Los Angeles, Los Angeles

94303

Stanford University, Palo Alto

98105

Seattle Childrens Hospital and Regional Medical Center, Seattle

02115

Children's Hospital, Boston, Boston

48201-2196

Children's Hospital of Michigan, Detroit

63110-1014

Washington University, St Louis

10032-1537

Columbia University, New York

75235-7794

UT Southwestern Medical Center, Dallas

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Shaddy, Robert, M.D.

INDIV